Veri seti Açık Erişim

'''Is It Possible To Visualize Efficiency of High Flow Nasal Cannula by Electrical Impedance Tomography ?''

özlem öner; Begüm Ergan; Esra Duğral; Ayşe sezin Kızıl; M.Çağatay Gürkök; Ali Necati Gökmen


DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.48623/aperta.228347</identifier>
  <creators>
    <creator>
      <creatorName>özlem öner</creatorName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-6171-2114</nameIdentifier>
      <affiliation>DOKUZ EYLÜL ÜNİVERSİTESİ</affiliation>
    </creator>
    <creator>
      <creatorName>Begüm Ergan</creatorName>
      <affiliation>DOKUZ EYLÜL ÜNİVERSİTESİ</affiliation>
    </creator>
    <creator>
      <creatorName>Esra Duğral</creatorName>
      <affiliation>Katip Çelebi EAH</affiliation>
    </creator>
    <creator>
      <creatorName>Ayşe sezin Kızıl</creatorName>
      <affiliation>DOKUZ EYLÜL ÜNİVERSİTESİ</affiliation>
    </creator>
    <creator>
      <creatorName>M.Çağatay Gürkök</creatorName>
      <affiliation>DOKUZ EYLÜL ÜNİVERSİTESİ</affiliation>
    </creator>
    <creator>
      <creatorName>Ali Necati Gökmen</creatorName>
    </creator>
  </creators>
  <titles>
    <title>'''Is It Possible To Visualize Efficiency Of High Flow Nasal Cannula By Electrical Impedance Tomography ?''</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2022</publicationYear>
  <subjects>
    <subject>Electrical ımpedans Tomography</subject>
    <subject>High Flow nasal cannula</subject>
    <subject>COVID-19</subject>
    <subject>ARDS</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2022-07-14</date>
  </dates>
  <resourceType resourceTypeGeneral="Dataset"/>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr//record/228347</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.48623/aperta.228346</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by-nd/4.0/">Creative Commons Attribution-NoDerivatives</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;&lt;strong&gt;ABSTRACT:&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;pre&gt;&lt;strong&gt;Background/Aim: &lt;/strong&gt;&lt;/pre&gt;

&lt;pre&gt;The aim of this study is to visualize the effect of a high flow nasal cannula&amp;nbsp; (HFNC) in patients with the diagnosis of COVID-19 acute respiratory distress syndrome followed up in intensive care unit (ICU) with the use of electrical impedance tomography (EIT). &lt;/pre&gt;

&lt;pre&gt;
&amp;nbsp;&lt;/pre&gt;

&lt;pre&gt;Materials and methods: &lt;/pre&gt;

&lt;pre&gt;In two different flow rates, in supine and prone positions, and with the help of HFNC, &amp;nbsp;oxygen therapy was applied. Patients&amp;rsquo; EIT-based parameters (global inhomogeneity index (GI index), Center of Ventilation (CoV), Regional Ventilation Delay index (RVD index), Region of Interest Ratio (ROI ratio)), respiratory &amp;nbsp;and hemodynamic parameters were recorded from the database.&lt;/pre&gt;

&lt;pre&gt;
&amp;nbsp;&lt;/pre&gt;

&lt;pre&gt;Results:&lt;/pre&gt;

&lt;p&gt;Bu retrospektif g&amp;ouml;zlemsel &amp;ccedil;alışmaya yirmi hasta dahil edildi. Akış hızı kademeli olarak taban &amp;ccedil;izgisinden 50 L / dak&amp;#39;ya ve eğilimli konuma y&amp;uuml;kseldiğinde; GI endeksinin anlamlı ve tutarlı bir d&amp;uuml;ş&amp;uuml;ş eğilimi: 0,55&amp;plusmn;0,02 (p &amp;lt; 0,0001), CoV: 42,98&amp;plusmn;0,93 (p &amp;lt;0,0001), RVD endeksi: 3,38&amp;plusmn;1,13 (p = 0,006), ROI oranı:1,39&amp;plusmn;0,16 (p &amp;lt;0,0001), respiartory oran: 21,3,3,57 (p &amp;plusmn; 0,0001), ortalama arteriyel basın&amp;ccedil;: 81,5&amp;plusmn;&amp;lt;10,95 (p=0,004) ve azalan PaO 2/FiO&lt;sub&gt;2. &lt;/sub&gt; oranı (kısmi arteriyel oksijen basıncı/esinlenmiş oksijen fraksiyonu): 203,1&amp;plusmn;33,44 ((p &amp;lt; 0.0001) g&amp;ouml;zlendi.&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;pre&gt;Conclusion:&lt;/pre&gt;

&lt;pre&gt;It is found using EIT parameters that in patients with COVID-19 ARDS, prone position and increasing flow rate decreases lung heterogeneity.&lt;/pre&gt;

&lt;pre&gt;
&amp;nbsp;&lt;/pre&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
    <description descriptionType="Other">{"references": ["Li Z, Zhang Z, Xia Q, Xu D, Qin S, Dai M, et al. First Attempt at Using Electrical Impedance Tomography to Predict High Flow Nasal Cannula Therapy Outcomes at an Early Phase. Front Med (Lausanne). 2021;8:737810.", "Zhang R, He H, Yun L, Zhou X, Wang X, Chi Y, et al. Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient. Crit Care. 2020;24(1):82."]}</description>
  </descriptions>
</resource>
46
76
görüntülenme
indirilme
Tüm sürümler Bu sürüm
Görüntülenme 4646
İndirme 7676
Veri hacmi 241.3 MB241.3 MB
Tekil görüntülenme 3939
Tekil indirme 77

Alıntı yap